Recent Insider Activity Could Benefit Corcept Therapeutics Inc (CORT)

Corcept Therapeutics Inc’s filing revealed that its Director Swisher Daniel N JR acquired Company’s shares for reported $0.16 million on Jul 10 ’25. In the deal valued at $71.08 per share,2,200 shares were bought.

Then, Guyer William sold 100 shares, generating $7,350 in total proceeds. Upon selling the shares at $73.50, the Chief Development Officer now owns 5,487 shares.

Before that, Lyon Joseph Douglas sold 100 shares. Corcept Therapeutics Inc shares valued at $7,350 were divested by the insider at a price of $73.50 per share. As a result of the transaction, Lyon Joseph Douglas now holds 10,066 shares, worth roughly $0.72 million.

Truist upgraded its Corcept Therapeutics Inc [CORT] rating to a Buy from a a Hold in a research note published on November 06, 2023; the price target was increased to $38 from $29. A number of analysts have revised their coverage, including SVB Securities’s analysts, who began to cover the stock in mid April with a ‘”a Market perform”‘ rating. Piper Sandler began covering CORT with “an Overweight” recommendation on April 04, 2023. Jefferies revised its rating on February 15, 2023. It rated CORT as “a Hold” which previously was an “a Buy”.

Price Performance Review of CORT

On Friday, Corcept Therapeutics Inc [NASDAQ:CORT] saw its stock fall -0.18% to $71.88. Over the last five days, the stock has lost -0.54%. Corcept Therapeutics Inc shares have risen nearly 140.40% since the year began. Nevertheless, the stocks have risen 42.65% over the past one year. While a 52-week high of $117.33 was reached on 03/31/25, a 52-week low of $30.77 was recorded on 01/13/25.

Levels Of Support And Resistance For CORT Stock

The 24-hour chart illustrates a support level at 70.57, which if violated will result in even more drops to 69.26. On the upside, there is a resistance level at 72.71. A further resistance level may holdings at 73.54.

How much short interest is there in Corcept Therapeutics Inc?

A steep rise in short interest was recorded in Corcept Therapeutics Inc stocks on 2025-06-13, growing by 0.17 million shares to a total of 12.65 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 12.48 million shares. There was a rise of 1.35%, which implies that there is a positive sentiment for the stock.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.